These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 12645935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.
    Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H, Kim J, Cosman D, Choi I.
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [Abstract] [Full Text] [Related]

  • 11. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M.
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
    Zhang T, Barber A, Sentman CL.
    Cancer Res; 2006 Jun 01; 66(11):5927-33. PubMed ID: 16740733
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
    Zwirner NW, Fuertes MB, Girart MV, Domaica CI, Rossi LE.
    Cytokine Growth Factor Rev; 2007 Jun 01; 18(1-2):159-70. PubMed ID: 17324607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.